Ultrasound-guided Caudal or Interlaminar Corticosteroid Epidural Injection for Sciatica
- Conditions
- Sciatica
- Interventions
- Procedure: interlaminarProcedure: ultrasound-guided
- Registration Number
- NCT02897336
- Lead Sponsor
- University Hospital, Caen
- Brief Summary
An open-label randomized trial to compare the efficacy of ultrasound-guided caudal and interlaminar corticosteroid injections for the treatment of lumbar disk herniation-related sciatica.
- Detailed Description
An open-label randomized trial conducted in one centre to compare the efficacy of ultrasound-guided caudal and interlaminar corticosteroid injections for the treatment of lumbar disk herniation-related sciatica. 30 male and female patients will be included in each group. The primary outcome measure will be a 30% decrease in lower limbs pain as assessed by a visual analog scale.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- radicular pain (sciatica or cruralgia) for more than 2 weeks
- failure of analgesics and NSAIDs
- without neurological deficiency (motor weakness lower or equal to 3/5)
- a lumbar disk herniation on MRI or CT dating less than 3 months
- history of lumbar surgery
- history of epidural injection during the last 3 months
- radicular pain not due to disk herniation
- a contraindication to epidural injection (infection, diabetes)
- history of allergic reaction to corticosteroid
- patient under legal guardianship
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description interlaminar interlaminar interlaminar epidural corticosteroid injection ultrasound-guided ultrasound-guided ultrasound-guided caudal epidural corticosteroid injection
- Primary Outcome Measures
Name Time Method lower limbs pain day 15 a 30% decrease in lower limbs pain using a visual analog scale
- Secondary Outcome Measures
Name Time Method Oswestry questionnaire day 15 - month 1 - month 3 - month 6 low back pain disability assessment using Oswestry questionnaire
neurological deficiency assessed by neurological examination day 15 - month 1 - month 3 - month 6 motor weakness or sensitive deficiency in lower limbs
medical outcome day 15 - month 1 - month 3 - month 6 Medical Outcome study Short Form (SF-36)
resumption of work day 15 - month 1 - month 3 - month 6 deadline of resumption of work
drugs day 15 - month 1 - month 3 - month 6 decrease in analgesic treatment
A decrease of radicular pain with a pain numerical scale lower or equal to 3/10 day 15 - month 1 - month 3 - month 6 pain numerical scale lower or equal to 3/10
number of patients with treatment-related adverse events as assessed by CTCAE v4.0 day 15 - month 1 - month 3 - month 6 adverse events assessed by CTCAE v4.0
Trial Locations
- Locations (1)
University Hospital
🇫🇷Caen, France